Trial Profile
Administration study of preparation containing the Doping Prohibited Substances to healthy adult males
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 12 Mar 2022
Price :
$35
*
At a glance
- Drugs Trimetazidine (Primary) ; Pentazocine; Tramadol
- Indications Angina pectoris; Eye disorders; Ischaemic heart disorders; Tinnitus; Vertigo
- Focus Adverse reactions
- 13 Nov 2018 New trial record